| Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC (NCT06348927) | Hunan Province Tumor Hospital | 2024-07-01 |
| Effects of an Antioxidant Supplement on Blood Vessel Health (NCT06424756) | University of Georgia | 2024-07-01 |
| Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab (NCT06371807) | Fundacao Champalimaud | 2024-07-01 |
| Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity (NCT05741606) | Tabriz University of Medical Sciences | 2024-07-01 |
| Safety and Efficacy of tPBM for Epileptiform Activity in Autism (NCT06352372) | Richard Frye | 2024-07-01 |
| Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer (NCT06407310) | Tel Aviv Medical Center | 2024-07-01 |
| Effects of THC on Alcohol Consumption and Neural Correlates of Reward (NCT06446479) | University of Colorado, Denver | 2024-07-01 |
| A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) (NCT06506292) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-01 |
| To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer (NCT06352008) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-01 |
| Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma (NCT06446726) | Sichuan University | 2024-06-30 |
| SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection (NCT03217617) | Shenzhen Geno-Immune Medical Institute | 2024-06-30 |
| Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors (NCT06446388) | Qilu Pharmaceutical Co., Ltd. | 2024-06-30 |
| Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma (NCT06430827) | Ba Yi | 2024-06-30 |
| SAINT for MDD in an Inpatient Setting Follow-on (NCT06462820) | Magnus Medical | 2024-06-30 |
| Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer (NCT06341296) | West China Hospital | 2024-06-30 |
| Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency (NCT06458686) | German University in Cairo | 2024-06-30 |
| CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial (NCT05958342) | Jason Sperry | 2024-06-30 |
| Pilot Study on Evaluating the Geroprotective Effect of Metformin (NCT06459310) | Xuanwu Hospital, Beijing | 2024-06-30 |
| Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC (NCT06475755) | Tang-Du Hospital | 2024-06-30 |
| Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors (NCT06462222) | Guangzhou Medical University | 2024-06-30 |
| T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma (NCT05756556) | ImmVira Pharma Co. Ltd | 2024-06-30 |
| A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL). (NCT06550336) | The First Hospital of Jilin University | 2024-06-30 |
| The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition (NCT03693105) | Magnus Medical | 2024-06-30 |
| Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis (NCT06372678) | Keymed Biosciences Co.Ltd | 2024-06-30 |
| An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer (NCT06468254) | Anhui Provincial Cancer Hospital | 2024-06-30 |
| A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD (NCT06558708) | Gan and Lee Pharmaceuticals, USA | 2024-06-28 |
| Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain (NCT06475001) | Vertanical GmbH | 2024-06-28 |
| A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma (NCT04629209) | Masonic Cancer Center, University of Minnesota | 2024-06-28 |
| HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma (NCT05962242) | University of Virginia | 2024-06-28 |
| A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis (NCT06392386) | argenx | 2024-06-28 |
| Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients (NCT06381986) | Sunhawk Vision Biotech, Inc. | 2024-06-28 |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread (NCT06324357) | Boehringer Ingelheim | 2024-06-28 |
| Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery (NCT06101745) | Curadel Surgical Innovations, Inc. | 2024-06-28 |
| Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) (NCT06458595) | Chengdu Origen Biotechnology Co., Ltd. | 2024-06-28 |
| Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL) (NCT06504940) | First Affiliated Hospital of Zhejiang University | 2024-06-28 |
| A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis (NCT06080789) | Panafina, Inc. | 2024-06-28 |
| CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT (NCT06453460) | University of California, Irvine | 2024-06-27 |
| A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma (NCT06485778) | Memorial Sloan Kettering Cancer Center | 2024-06-27 |
| CAN1012 Combined With PD-1 in Patients With Solid Tumors (NCT06410703) | Canwell Biotech Limited | 2024-06-27 |
| Randomized Study Using SM-030 Gel for Adults With Melasma (NCT06454747) | DermBiont, Inc. | 2024-06-27 |
| To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus (NCT06481085) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2024-06-27 |
| PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer. (NCT06369246) | M.D. Anderson Cancer Center | 2024-06-27 |
| Modulation of THC Effects by CBD: a Dose-ranging Study (NCT06099379) | Centre hospitalier de l'Université de Montréal (CHUM) | 2024-06-27 |
| Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) (NCT05224960) | Beijing 302 Hospital | 2024-06-27 |
| Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis. (NCT06253117) | University of Alabama at Birmingham | 2024-06-27 |
| A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants (NCT06454630) | Regeneron Pharmaceuticals | 2024-06-27 |
| Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery (NCT06349590) | University of Chicago | 2024-06-27 |
| Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over (NCT06515418) | BioAge Labs, Inc. | 2024-06-27 |
| PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product (NCT03984565) | Staci Gruber, Ph.D. | 2024-06-27 |
| Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer (NCT06006923) | Anwaar Saeed | 2024-06-26 |
| Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma (NCT06353022) | Nantes University Hospital | 2024-06-26 |
| Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC (NCT06494943) | Fudan University | 2024-06-26 |
| Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy (NCT06478953) | Chinese University of Hong Kong | 2024-06-26 |
| Trilaciclib Prevents Myelosuppression With Chemoradiotherapy (NCT06490081) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-06-26 |
| Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies (NCT06383572) | M.D. Anderson Cancer Center | 2024-06-26 |
| Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars. (NCT07264842) | Dow University of Health Sciences | 2024-06-26 |
| A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis (NCT06478706) | Enterprise Therapeutics Ltd | 2024-06-26 |
| A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) (NCT06064097) | National Cancer Institute (NCI) | 2024-06-25 |
| Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial (NCT06855095) | The Netherlands Cancer Institute | 2024-06-25 |
| pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD) (NCT06253507) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-06-25 |
| Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia (NCT06608342) | Institute of Hematology & Blood Diseases Hospital, China | 2024-06-25 |
| Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS) (NCT06211933) | Centre Leon Berard | 2024-06-25 |
| A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults (NCT06475846) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-06-25 |
| IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease (NCT06400459) | IVIEW Therapeutics Inc. | 2024-06-25 |
| A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors (NCT06475300) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-06-25 |
| Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury. (NCT06146062) | Assistance Publique - Hôpitaux de Paris | 2024-06-25 |
| To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization (NCT06478719) | Febico Biomedical Corp. | 2024-06-24 |
| A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist (NCT06500429) | Neurogastrx, Inc. | 2024-06-24 |
| Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis (NCT06429176) | SpliSense Ltd. | 2024-06-24 |
| Obinutuzumab in Treatment of Fibrillary Glomerulonephritis (NCT06295770) | Mayo Clinic | 2024-06-24 |
| Personalized Antisense Oligonucleotide for a Single Participant With CHCHD10 ALS (NCT06977451) | n-Lorem Foundation | 2024-06-24 |
| Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib (NCT06582745) | Cook Children's Health Care System | 2024-06-24 |
| Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial (NCT06203600) | National Cancer Institute (NCI) | 2024-06-24 |
| HP Pyruvate MRI in Cancers (NCT05697406) | University of Maryland, Baltimore | 2024-06-24 |
| Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants (NCT06878742) | Instituto de Investigación Hospital Universitario La Paz | 2024-06-24 |
| The Medically Reproducing Bariatric Surgery (MRB) II Study (NCT06363747) | Durham VA Medical Center | 2024-06-24 |
| BHV-7000 Open-Label Extension Bipolar Mania Study (NCT06423794) | Biohaven Therapeutics Ltd. | 2024-06-24 |
| A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis (NCT06159725) | Clarametyx Biosciences, Inc. | 2024-06-24 |
| Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer (NCT05775471) | Jonsson Comprehensive Cancer Center | 2024-06-24 |
| Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer. (NCT06778382) | Shandong Cancer Hospital and Institute | 2024-06-24 |
| Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy (NCT06459193) | Minia University | 2024-06-23 |
| Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV (NCT06782685) | Dai, Guanghai | 2024-06-23 |
| Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial (NCT07278128) | Fateme Moshirenia | 2024-06-22 |
| Effect of Dexmedetomidine on Hemodynamic Response to Endotracheal Intubation in Hypertensive Patients (NCT06712186) | Liaquat National Hospital & Medical College | 2024-06-22 |
| Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer (NCT06734182) | Guangdong Provincial People's Hospital | 2024-06-22 |
| Effect of Topical Insulin on Healing Rate of Pemphigus Lesions (NCT07461103) | Alexandria University | 2024-06-22 |
| A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations (NCT06370351) | Sensorion | 2024-06-21 |
| Anifrolumab for Hidradenitis Suppurativa (NCT06374212) | University of North Carolina, Chapel Hill | 2024-06-21 |
| A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT06378177) | Lyvgen Biopharma Holdings Limited | 2024-06-21 |
| Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma (NCT06288191) | Melanoma Institute Australia | 2024-06-21 |
| A Study of Sacituzumab Govitecan in People With Mesothelioma (NCT06477419) | Memorial Sloan Kettering Cancer Center | 2024-06-21 |
| Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer (NCT06067438) | OHSU Knight Cancer Institute | 2024-06-21 |
| Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion (NCT06033092) | European Institute of Oncology | 2024-06-21 |
| A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects (NCT06252961) | Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 2024-06-21 |
| Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang (NCT06912035) | Universitas Sriwijaya | 2024-06-21 |
| A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer (NCT06483282) | Jin Ying | 2024-06-21 |
| BeFluBu vs FluBuRux Conditioning in Haploidentical HCT (NCT06477549) | St. Petersburg State Pavlov Medical University | 2024-06-21 |
| Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes (NCT06415214) | Shandong Suncadia Medicine Co., Ltd. | 2024-06-21 |
| A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures (NCT06425159) | Biohaven Therapeutics Ltd. | 2024-06-20 |
| Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma (NCT06416930) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-06-20 |